These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39141072)

  • 1. Mechanism exploration of synergistic photo-immunotherapy strategy based on a novel exosome-like nanosystem for remodeling the immune microenvironment of HCC.
    Chen Y; Li X; Shang H; Sun Y; Wang C; Wang X; Tian H; Yang H; Zhang L; Deng L; Yang K; Wu B; Cheng W
    Nano Converg; 2024 Aug; 11(1):31. PubMed ID: 39141072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
    Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
    ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo-Immunotherapy.
    Zhang R; Ye Y; Wu J; Gao J; Huang W; Qin H; Tian H; Han M; Zhao B; Sun Z; Chen X; Dong X; Liu K; Liu C; Tu Y; Zhao S
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17627-17640. PubMed ID: 37000897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
    Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
    Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 6. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Cellular Nanovesicles Block PD-L1 Signal and Repolarize M2 Macrophages for Cancer Immunotherapy.
    Zhao C; Pan Y; Liu L; Zhang J; Wu X; Liu Y; Zhao XZ; Rao L
    Small; 2024 Aug; 20(31):e2311702. PubMed ID: 38456371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking siglec-10
    Xiao N; Zhu X; Li K; Chen Y; Liu X; Xu B; Lei M; Xu J; Sun HC
    Exp Hematol Oncol; 2021 Jun; 10(1):36. PubMed ID: 34112250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional 2D Iron-Based Nanosheets for Synergistic Immunotherapy, Phototherapy, and Chemotherapy of Tumor.
    Wang X; Cheng Y; Han X; Yan J; Wu Y; Song P; Wang Y; Li X; Zhang H
    Adv Healthc Mater; 2022 Oct; 11(19):e2200776. PubMed ID: 35912918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioactive nanocomposite integrated specific TAMs target and synergistic TAMs repolarization for effective cancer immunotherapy.
    Gu W; Guo W; Ren Z; Zhang Y; Han M; Zhao Q; Gao Y; Mao Y; Wang S
    Bioact Mater; 2024 Aug; 38():472-485. PubMed ID: 38779591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
    Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
    Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
    J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2
    Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
    J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy.
    Kang Y; Yan J; Han X; Wang X; Wang Y; Song P; Su X; Rauf A; Jin X; Pu F; Zhang H
    ACS Appl Mater Interfaces; 2024 Jul; 16(28):36131-36141. PubMed ID: 38979627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
    Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
    Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation.
    Du Y; Qian X; Lin F; Gao B; Wang W; Yang H; Wang W; Ding Y
    Acta Biomater; 2023 May; 162():85-97. PubMed ID: 36948328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
    Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
    Front Immunol; 2020; 11():1731. PubMed ID: 32849616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
    Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
    ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.